Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 2:15 AM
Ignite Modification Date:
2025-12-25 @ 2:15 AM
NCT ID:
NCT04361760
Eligibility Criteria:
Inclusion Criteria:
* Informed consent as documented by signature
* Age between 20-30 or 65-75 years
* Neurologically healthy, i.e., with no documented or present neurological disease or brain injury
* Normal or corrected-to-normal visual acuity
Exclusion Criteria:
* Any instable medical condition, in particular epilepsy (past or present, including seizures or febrile convulsions)
* Any surgical intervention to the brain
* Heart diseases
* Implanted medical devices (e.g., cochlear implants, infusion pumps, neurostimulators, pacemakers)
* History of migraine or strong headaches
* Sleep deprivation
* Presence of non-MRI safe metal in the body
* Drug or alcohol abuse
* Intake of any medication that is likely to lower seizure threshold
* Claustrophobia
* For female participants: in order to participate in the study, female participants in reproductive age need to take a pregnancy test (a standard urine pregnancy test will be provided).
* For female participants: breastfeeding
* Inability to follow the procedures of the study, e.g. due to language problems, psychological disorders, etc. of the participant
* Lack of knowledge of the German language
* Participation in another study with investigational drug within the 30 days preceding and during the present study
* Previous enrolment into the current study
* Enrolment of the investigator, his/her family members, employees and other dependent persons
Healthy Volunteers:
True
Sex:
ALL
Minimum Age:
20 Years
Maximum Age:
75 Years
Study:
NCT04361760
Study Brief:
Protocol Section:
NCT04361760